The K601E mutant falls into this class, has been shown to result in elevated levels of phospho-MEK and phospho-ERK in tumors in which it is found, and has been described in melanoma and in colon and thyroid cancers. This evidence concerns the gene MAP2K7 and thyroid cancer.